For National Alzheimer’s Awareness Month, explore LSF-supported research by @ScheibyeKnudsen at the University of Copenhagen into senescent astrocytes and potential future treatments.
Support the project: https://t.co/MMijojF64x
#endalz#endalzheimers#longevity
Longer, healthier lives have implications for financial planning. Join our CEO Joshua Herring and Bridget Venus Grimes, Founder of @EquitaFn, for “Rethinking Financial Planning for Longer, Healthier Lives” on Dec 2 at 4:00 PM EST:
https://t.co/Z9uyu6sIqB
Full interview: I was live on @FoxNews@SatAmericaFNC. AI-designed drugs for aging and disease, GLP-1s, our IPF drug, and why we should prepare to live to 150. Thank you Brian Yennis for having me! #ARDD2026 https://t.co/KNYxg86AQ1
@Grimezsz By 2030, ~1.2 billion women will be approaching or in menopause, with significant implications for female healthspan. We encourage you to check out our Invested in Her campaign which supports research into ovarian aging. 100% of donations go to research: https://t.co/fEGQNAnipO
“Natural” doesn’t mean safe. Our latest Hype vs. Reality article explores experimental #peptides, gaps in human safety data, risks from unregulated products, and what we know about GLP-1 medicines. #longevity
https://t.co/eUhV5B1AuW
AI can find a new drug candidate in days. So why does it take years to reach you?
@biogerontology says people “overestimate the capabilities of AI and underestimate the complexity of biology.” For some conditions, trials still take a decade.
That gap is now on @OpenAI's radar. This week, it bought Orchestra Bio, which uses AI agents to keep drug programmes on track.
A day later, an @AgingCell study found that the postmenopausal ovary stays biologically active for decades rather than going dormant. We're only scratching the surface of #menopause: https://t.co/hyLv9yqemD
Support our Invested in Her Campaign: https://t.co/fEGQNAnipO
Long-overdue study of menopause reveals it begins more than a decade before the final period. Uri Alon and collaborators analyze 300 million tests and use a mathematical technique from astronomy to shows HRT can delay many deleterious changes 🧵
Peptides are being widely discussed, but how strong is the science?
Our latest Hype vs. Reality article explores GLP-1 medicines, separating established clinical evidence from promising but preliminary findings.
Read more: https://t.co/ZdEPZFNxax
#peptides#GLP1#longevity
At @ARDD_Meeting 2026, the @FDA said #aging and #longevity will be included in its next regulatory science agenda. Officials discussed trials, biomarkers and collaboration.
Read the @LifespanRI article by @ArkadyMazin: https://t.co/lqK2l5jFpa
Day 1 of #ARDD2026 opens at Harvard. George Daley, Dean of Harvard Medical School, kicks off the 13th Aging Research & Drug Discovery Meeting. Full program: https://t.co/J8vdGrikQW
Peptides are everywhere in conversations about weight loss, recovery, skin health, metabolism, and #longevity. But what are they, really? Our article explores what #peptides are, how they work, and how to separate science from hype.
Read more: https://t.co/9XdyCY48td
Colleagues from @metabesity and @APACLongevity are hosting the 2026 Asia-Pacific Healthy Longevity International Summit, Oct 1-4 in Hong Kong, with 1,000+ attendees and speakers including our Scientific Advisors, @mkaeberlein and @AndreaBMaier. Learn more: https://t.co/MPOistHyBl
Six proteomic #aging clocks showed reductions in predicted biological age among rentosertib-treated participants in a Phase 2a trial of @InsilicoMedicine drug for IPF. Congratulations to Insilico CEO and our scientific advisor @biogerontology and the team! https://t.co/Qj1Ae8MUxw
For the first time, people 65+ outnumber children ≤5 worldwide, @axios reports. Longer lives are an achievement, but longer life does not always mean longer health. As populations age, investing in #healthspan is increasingly urgent.
https://t.co/rlR2EiVu8o
#aging#longevity
The @USC has received a $7.5M @NIH grant to establish GeroSCORE, advancing research into sex differences in #aging, including #menopause and brain aging.
Progress in the field is being made, but major gaps remain. Help fund women’s health research: https://t.co/q37LhdXYG4
The Longevity Science Foundation (@longescience) is extending the deadline for its Invested in Her campaign to October 1, 2026, as they work to support early-stage research into ovarian aging and menopause.
👉 Read more: https://t.co/u3QH6O6Ne0